NCT05977933View on ClinicalTrials.gov

Assessing the Utility of Submaximal CPET in Treatment Management of PAH

Not yet recruitingOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

December 30, 2024

Conditions
Pulmonary Arterial Hypertension
Interventions
DEVICE

Shape II CPET

Submaximal Cardiopulmonary exercise test equipment

Trial Locations (6)

90502-2006

Harbor-UCLA Medical Center, Torrance

80206-2761

National Jewish Health, Denver

32224-1865

Mayo Clinic, Jacksonville

30312-1213

WellStar Health System, Atlanta

31904-7955

Southeastern Cardiology, Columbus

10021-9800

Weill Cornell Medicine, New York

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Shape Medical Systems, Inc.

INDUSTRY

NCT05977933 - Assessing the Utility of Submaximal CPET in Treatment Management of PAH | Biotech Hunter | Biotech Hunter